Last verified: April 22, 2026 · Pricing pulled directly from ro.co and joinfound.com · Formulary confirmed against manufacturer sources
Provider Comparison · April 22, 2026
Ro vs Found for Weight Loss: Which GLP-1 Program Actually Wins in 2026?
Verified comparison of Ro Body and Found Health on price, insurance, medications, coaching, and cancellation. Last verified: April 22, 2026.
The short answer: for most people comparing Ro vs Found in 2026, Ro is the better choice. Ro publishes transparent pricing, carries every currently available FDA-approved GLP-1 for weight loss — Wegovy pen, Wegovy pill, Zepbound pen, Zepbound KwikPen, Foundayo, and Ozempic — includes metabolic lab testing at Quest when ordered, and runs a dedicated insurance concierge that fights for coverage and submits your prior authorization paperwork for you. Found is the better fit if coaching, community, and broader non-GLP-1 medication options matter to you more than pricing transparency.
Bottom line by situation:
- • Want brand-name Wegovy, Zepbound, Foundayo, or Ozempic → Ro
- • Want coaching-first, community-driven weight care → Found
- • Want the lowest compounded semaglutide cash-pay price → neither; see alternatives below
- • Already have a prescription and a pharmacy → skip both and use LillyDirect or NovoCare directly
Ready to check your GLP-1 eligibility on Ro?
Check your GLP-1 eligibility on Ro →Start for $39 your first month, then as low as $74/month with an annual plan paid upfront.
The 30-second snapshot: Ro vs Found at a glance
Verified against ro.co and joinfound.com on April 22, 2026. Figures shift; we re-verify monthly.

The simplest way to think about it: choose Ro for a cleaner path to brand-name GLP-1 treatment and stronger insurance support. Choose Found for a more coaching-led experience with broader lifestyle support.
| Factor | Ro (Ro Body) | Found (Found Health) |
|---|---|---|
| Starting membership price | $39 first month, then $149/month monthly or as low as $74/month on annual prepay | Varies by plan; CORE self-pay is $129/month (new patients may receive a first-month discount) |
| FDA-approved GLP-1 formulary | Wegovy pill, Wegovy pen, Zepbound pen, Zepbound KwikPen, Foundayo, Ozempic, Saxenda | Wegovy, Zepbound, Foundayo, Ozempic, Mounjaro, Rybelsus, Saxenda, Trulicity, Victoza |
| Non-GLP-1 weight-loss medications | Limited | Yes — Contrave, metformin, topiramate, zonisamide |
| Insurance concierge | Yes — fights for coverage, submits all PA paperwork | Yes — free coverage check; supports PA documentation |
| Labs with membership | Metabolic testing at any Quest location included when ordered | Not included; lab costs billed separately |
| Cancellation | Cancel any time, 48-hour notice; no early termination fee | Cancel any time; $129 early termination fee on Pay Monthly and Pay Quarterly CORE plans before day 151 |
| Best for | Brand-name GLP-1 seekers, insured readers, pill-first buyers, transparent pricing | Coaching-first readers, broader medication menu, non-GLP-1 combinations |
| Our verdict | Wins for most people in 2026 | Wins for coaching-first readers specifically |
What’s different about this comparison: Most pages ranking for “Ro vs Found” were written before Ro became a launch partner for Foundayo on April 9, 2026 and before the Wegovy pill rollout in December 2025. Those two formulary additions change who wins this comparison for anyone who wants a pill instead of an injection.
Is Ro or Found better for most people in 2026?
For most readers comparing these two programs in 2026, Ro wins. Its pricing is easier to verify across pages, its insurance workflow is better documented, and it publicly offers every FDA-approved GLP-1 for weight loss. We don’t say “Ro wins for most people” because of brand bias — we say it because the public evidence is cleaner.
Choose Ro if…
- You want Wegovy, Zepbound, Foundayo, or Ozempic
- You have commercial insurance and want PA paperwork submitted for you
- You want an oral pill option
- You want metabolic labs at Quest included when ordered
- You want transparent cancellation with no ETF
- You want medication priced at LillyDirect / NovoCare rates
Choose Found if…
- You specifically want 1:1 coaching and a peer community
- You want a behavior-change-first program
- You want non-GLP-1 options like Contrave, metformin, or topiramate
- You’re comfortable with a more complex plan structure for personalization
Choose neither if…
- Your only priority is cheapest compounded cash-pay
- You already have a prescription and just need it filled
- You want premium plateau-breaker care with lab-guided dose adjustments
$39 first month. As low as $74/month with annual plan paid upfront.
How do Ro and Found compare on real monthly cost?
Ro Body costs $39 the first month, then $149/month on a monthly plan or as low as $74/month on annual prepay, with medication billed separately at matched LillyDirect, NovoCare, and TrumpRx pricing. Found’s CORE self-pay plan is $129/month; PLUS and branded GLP-1 plans run higher. Your actual monthly cost depends on which medication you take and whether insurance covers it.
Ro pricing (verified from ro.co/weight-loss/pricing/)
| Item | Verified price |
|---|---|
| Intro month | $39 |
| Monthly plan ongoing | $149/month |
| Annual prepay | As low as $74/month |
| Wegovy pill (cash-pay medication) | $149 first month, then $199–$299/month (starter doses) |
| Foundayo pill (cash-pay medication) | $149 first month, then $199–$299/month (starter doses) |
| Zepbound KwikPen | $299 first month, then $399–$449/month |
| Wegovy pen | $199 first month, then $199–$349/month (Prepay & Save: $100/month off with annual plan) |
| Ozempic | $900–$1,100/month without insurance (off-label for weight loss at provider discretion) |
| Labs at Quest (provider-ordered) | Included; at-home kit $75, or free in NY, NJ, RI, ND, SD, WY |
Found pricing (verified from joinfound.com)
| Plan | Verified rate |
|---|---|
| Pay Monthly CORE Subscription | $129 every 30 days after first month ($39 clinical assessment credited against first month) |
| Pay Quarterly CORE Plan | $348 every 90 days ($696 total for 6-month initial term); converts to Pay Monthly CORE after |
| Pay Biannually CORE Plan | $594 prepaid for 6 months; auto-converts to Pay Monthly CORE |
| Found Kickstart (3-, 6-, or 12-month) | $74.99/month with contractual obligation through final month of selected program |
| PLUS Subscription Plan | Higher-tier self-pay; pricing varies |
| Insurance-eligible plans | Available when Found is in-network; pricing varies by coverage |
| Medication | Branded GLP-1 billed separately; labs not included in membership |
28-day vs 30-day billing at Found: some Found offer pages use a 28-day billing cycle instead of 30-day monthly. That means 13 billing cycles per 52 weeks. On a $129/28-day plan you pay roughly $1,677 per year instead of $1,548 on a 30-day cycle. Small gap, real gap. Ro bills monthly.
The six realistic scenarios — what you’ll actually pay
| # | Medication | Insurance | Ro est. monthly cost | Found est. monthly cost | Winner |
|---|---|---|---|---|---|
| 1 | Wegovy pen, maintenance | Commercial, covers GLP-1s | $74–$149 membership + $0–$25 medication (PA + savings card) | Found plan fee + $0–$25 medication | Ro — concierge submits and fights PA |
| 2 | Wegovy pill, cash-pay | None / no GLP-1 | $39 first mo + $149 medication; $74–$149/mo ongoing + $199–$299 medication | Found plan fee + medication (plan-dependent pricing) | Ro — matched to NovoCare, published directly |
| 3 | Foundayo pill, cash-pay | None / no GLP-1 | $39 first mo + $149 medication; $74–$149/mo ongoing + $199–$299 medication | Found plan fee + medication (plan-dependent pricing) | Ro — launch partner, matched to LillyDirect |
| 4 | Zepbound KwikPen, cash-pay | None | $39 first mo + $299 medication; $74–$149/mo + $399–$449 medication | Found plan fee + Zepbound (plan-dependent pricing) | Ro — transparent tiered pricing, broader Zepbound formats |
| 5 | Compounded semaglutide, cash-pay | Any | $39 first mo + compounded medication where available | Lower-tier Found plan may be cheaper; availability varies | Neither specializes |
| 6 | Oral pill preference (unsure which) | Any | Ro: Wegovy pill + Foundayo at transparent cash-pay pricing | Found: Rybelsus, Wegovy pill, Foundayo — pricing plan-dependent | Tied on breadth; Ro wins on pricing clarity |
Ro wins outright in 4 of 6 scenarios. Scenario 5 (compounded-only) routes to neither. If compounded semaglutide is specifically what you want, read dedicated reviews of Eden, MEDVi, or SHED instead.
Transparent membership. Medication at matched-manufacturer rates.
Which medications can you actually get through Ro vs Found?
Ro carries every FDA-approved GLP-1 for weight loss currently on the US market. Found carries a broader list including more diabetes-indication medications prescribed off-label, plus non-GLP-1 weight-loss options. Both providers now carry the Wegovy pill and Foundayo.
Ro’s 2026 FDA-approved lineup (verified April 22, 2026)
- Wegovy pill (oral semaglutide) — FDA approved December 2025
- Wegovy pen (semaglutide injection)
- Zepbound pen (tirzepatide injection)
- Zepbound KwikPen (tirzepatide injection)
- Foundayo (orforglipron, oral) — FDA approved April 1, 2026; Ro launch partner April 9, 2026
- Ozempic (semaglutide injection) — diabetes indication; off-label for weight loss
- Saxenda (liraglutide) — FDA-approved for chronic weight management
Found’s lineup (verified April 22, 2026)
- Wegovy, Zepbound, Foundayo — FDA-approved for weight management
- Ozempic, Mounjaro, Trulicity, Victoza — diabetes indication; off-label for weight loss
- Rybelsus (oral semaglutide) — diabetes indication; off-label for weight loss
- Saxenda — FDA-approved for chronic weight management
- Non-GLP-1: Contrave, metformin, topiramate, zonisamide
Found is not Foundayo — the disambiguation that trips people up
- Found (or Found Health) = a telehealth company that prescribes weight-loss medications
- Foundayo (orforglipron) = Eli Lilly’s FDA-approved oral GLP-1 pill for chronic weight management, approved April 1, 2026
Both Ro and Found the telehealth company offer Foundayo the medication. If you specifically want Foundayo the pill, both platforms can prescribe it. Ro publishes transparent cash-pay pricing at $149 first month, then $199–$299/month thereafter.
See Foundayo and Wegovy pill pricing on Ro →Both FDA-approved weight-loss pills. Matched to LillyDirect and NovoCare. Starter dose $149 your first month.
Compounded GLP-1s: both have them; neither is the specialist
Compounded semaglutide and tirzepatide are prepared by licensed compounding pharmacies and are not FDA-approved as finished drug products. The FDA has raised specific safety concerns about dosing errors and salt forms in compounded injectable semaglutide. If compounded cash-pay is specifically your goal, Eden, MEDVi, or SHED are better matches.
Which program is better if insurance is part of the plan?
Ro has the more hands-on insurance workflow. Ro’s insurance concierge team fights for coverage and submits your prior authorization paperwork, then suggests a cash-pay alternative if coverage falls through. Found runs a free GLP-1 coverage checker — it contacts your insurer, returns a coverage report, and supports PA documentation — but more of the PA filing lift sits with you or your prescribing clinician.
| Insurance step | Ro | Found |
|---|---|---|
| Coverage check | Free GLP-1 Insurance Coverage Checker (no membership required) | Free coverage check; contacts insurer; returns personalized report |
| Prior authorization | Concierge fights for coverage and submits all paperwork on your behalf | Supports PA documentation; more filing lift on member or clinician |
| If coverage fails | Provider recommends FDA-approved cash-pay alternative at matched manufacturer rates | Cash-pay medication available on applicable plans |
| Timeline (cash-pay path) | Eligibility within 2 days; first dose under a week | Assessment + review 1–2 days; first-dose timelines vary |
| Medicare/Medicaid/TRICARE | Medicare, Medicare supplement, TRICARE members can join and pay cash for certain options; Medicaid excluded; FEHB permitted | Insurance-priced plans also restrict government-plan members |
Medicare Part D members: the Medicare GLP-1 Bridge runs July 1, 2026 through December 31, 2027, covering Wegovy (injection and tablets) and Zepbound for weight loss at a $50 copay for eligible beneficiaries. Foundayo was added to the Bridge on April 6, 2026. This program operates through a central CMS processor outside both telehealth providers and outside Part D plans. See our Medicare GLP-1 Bridge guide for full details.
What do you get for support, coaching, and labs?
What Found includes
- 1:1 coaching (nutrition, behavior change, mindfulness)
- In-app peer community
- Self-paced lifestyle change program
- AI assistant in-app
- Clinician-led care from obesity medicine providers
- 13 weight-loss medication options
Found’s positioning: coaching-first and personalization-first. “We consider not only your weight goals but your entire health profile, medication sensitivities, lifestyle, and financial circumstances.”
What Ro includes
- FDA-approved GLP-1 medications (every current option)
- Dedicated insurance concierge
- Unlimited provider messaging
- Side-effect management and titration support
- Weight tracking and dose logging
- 1:1 health coaching
- Metabolic testing at any Quest Diagnostics when ordered
- Board-certified obesity-medicine physician on team
| Priority | Better fit |
|---|---|
| Someone to check on you and hold you accountable | Found |
| Peer community of other people on GLP-1s | Found |
| Clinical access, labs at Quest, PA paperwork submitted for you | Ro |
| Board-certified obesity-medicine physician publicly named | Ro |
| Broad non-GLP-1 options in case GLP-1s don’t work | Found |
Ro member outcomes (from a Ro-commissioned survey of 1,243 members taking GLP-1 medication for at least 7 weeks paired with diet and exercise, per ro.co): 87% report life-changing results; 93% agree Ro is easier to incorporate into their lives; 97% report silenced or quieter food noise. Results vary; the survey reflects self-reported satisfaction. Ro discloses that member testimonials on its site were compensated.
Where Ro falls short — and why it still wins for most people
Ro is not the cheapest GLP-1 program on the market. At $149/month on the monthly plan, its membership is higher than several compounded-focused telehealth platforms that bundle the medication into a single flat fee. If your only goal is the lowest possible monthly bill, Ro is not your provider.
For anyone who wants FDA-approved brand-name medication, insurance support, or transparent cancellation, Ro’s price buys what the cheaper options don’t: an insurance concierge that submits your prior authorization, metabolic labs included at Quest when ordered, matched LillyDirect / NovoCare / TrumpRx cash-pay pricing on the medications themselves, and a formulary that includes every FDA-approved GLP-1 for weight loss on the US market.
For readers where price is the absolute top priority and compounded is fine:
- Eden — broad default; HSA/FSA; strong compounded value
- MEDVi — deepest compounded menu; broad cash-pay value
- SHED — oral / sublingual / needle-averse specialist in the compounded lane
- Enhance MD — premium clinical-feel with lab work; best for plateau or stronger-protocol seekers
Which platform is easier to cancel — and which creates more billing friction?
Short answer: Ro’s cancellation is simple — no early termination fee on the monthly plan. Found’s CORE Subscription Plans carry a $129 early termination fee if you cancel before day 151.
| Cancel detail | Ro | Found |
|---|---|---|
| How to cancel | In-account or via email to Ro support | Via support email or in-app “Cancel Membership” |
| Notice required | 48 hours before next billing date | Within 24 hours (36 hours on some CORE plan versions) |
| Early termination fee | None on monthly plan | $129 if you cancel before day 151 on Pay Monthly or Pay Quarterly CORE plan |
| Kickstart plans (Found only) | — | Obligated to pay all remaining fees through final month of 3-, 6-, or 12-month program at $74.99/month |
| Refund policy | Paid membership fees non-refundable | Some plans include 3-day full-refund window and pre-first-consultation refund option |
| Billing cycle | Monthly (30-day) | Monthly or 28-day (13 cycles/year on some plans) |
State availability, HSA/FSA, and other edge cases
State availability
Ro’s FDA-approved brand-name GLP-1s are available in nearly every US state. Ro ships free at-home blood collection kits to NY, NJ, RI, ND, SD, and WY where Quest isn’t convenient. Found operates across most US states with similar branded GLP-1 coverage. Compounded semaglutide availability at both providers depends on state law and current FDA guidance, which tightened significantly in 2026 after the semaglutide shortage was resolved in February 2025.
HSA and FSA
Prescription GLP-1 medications for qualifying medical conditions (obesity BMI 30+ or overweight BMI 27+ with a weight-related comorbidity) are generally HSA and FSA eligible at both providers. Membership fees themselves may or may not qualify depending on your plan administrator’s definition of qualified medical expenses. Confirm with your benefits administrator.
Government insurance
Neither provider coordinates coverage for Medicare, Medicaid, or TRICARE. Per ro.co, Medicare, Medicare supplement, and TRICARE members can join Ro Body and pay cash for certain options; Medicaid members cannot join the Ro Body membership. FEHB members can join Ro Body and access the insurance concierge. Found’s insurance-priced plans also restrict government-plan members.
What happens after the first month
- Ro: $39 first month → $149/month ongoing on monthly plan, or $74/month equivalent on annual prepay. Medication billed separately.
- Found: Your plan rate continues at your selected cadence. CORE commitment plans carry the $129 ETF if you exit before day 151. Medication billed separately on branded GLP-1 plans.
What real users say about Ro and Found
We’re using these quotes as voice-of-customer evidence for service experience only — not as evidence for medical efficacy or safety. Individual results vary. Testimonials on Ro’s own site disclose that members were compensated.
“I was not expecting insurance help. Usually patients are their own advocate, so I was thrilled to not have to fight for my coverage.”
— Hannah, Ro member (paid testimonial on ro.co)
“I did my research, but nothing came close to what Ro offered.”
— Greg, Ro member (paid testimonial on ro.co)
“What I like most about Found is how nonjudgmental they are. Their program is tailored to me, it’s affordable, I appreciate that the payments have been monthly instead of quarterly.”
— Verified Found member (Trustpilot, 2026)
“My experience has been tailored to me and my needs. I am able to reach out to my care team at any time to discuss issues that arise with me or changes in medication.”
— Verified Found member (Trustpilot, 2026)
Most common Ro complaint: frustration with the cancellation window and monthly membership billing if medication access is interrupted. Most common Found complaints: billing disputes on committed plans, surprise over the ETF, inconsistent coaching quality.
When should someone choose Found instead of Ro?
Choose Found when coaching, community, and a broader behavior-change framework matter to you more than pricing transparency and insurance concierge depth.
| Goal | Best fit |
|---|---|
| 1:1 coaching and peer community built into the product | Found |
| Behavior change support more than medication-access efficiency | Found |
| Non-GLP-1 weight-loss medications (Contrave, metformin, topiramate) | Found |
| Brand-name GLP-1 (Wegovy, Zepbound, Foundayo, Ozempic, Saxenda) | Ro |
| Insurance concierge that submits and fights PA paperwork | Ro |
| Oral pill option (Foundayo or Wegovy pill) with transparent cash-pay pricing | Ro |
| Metabolic labs at Quest included when ordered | Ro |
| Transparent cancellation, no early termination fee | Ro |
| Cheapest compounded cash-pay GLP-1 | Neither → Eden, MEDVi, or SHED |
| Premium plateau-breaker with lab-guided dose adjustments | Neither → Enhance MD |
| Not sure what you need? | Take our free 60-second GLP-1 matching quiz → |
Ro vs Found: frequently asked questions
Is Ro or Found better for weight loss?
For most people comparing Ro vs Found in 2026, Ro is the better choice. Ro publishes transparent pricing, carries every currently available FDA-approved GLP-1 for weight loss, includes metabolic lab testing at Quest when ordered, and runs a dedicated insurance concierge that fights for coverage and submits prior authorization paperwork. Found is the better fit for readers who specifically want 1:1 coaching, a peer community, behavior-change support, and a broader non-GLP-1 medication menu.
Is Found the same as Foundayo?
No. Found (or Found Health) is a telehealth company that prescribes weight-loss medications. Foundayo (orforglipron) is Eli Lilly’s FDA-approved oral GLP-1 pill for chronic weight management, approved April 1, 2026. Both Ro and Found the telehealth company offer Foundayo the medication. The names collide and cause frequent confusion.
Does Ro have the Wegovy pill and Foundayo?
Yes. Ro offers the Wegovy pill (oral semaglutide, FDA-approved December 2025) at $149 the first month then $199–$299/month, and Foundayo (orforglipron, FDA-approved April 1, 2026) at $149 the first month then $199–$299/month. Ro was a launch partner for Foundayo on April 9, 2026.
Does Found have Foundayo?
Yes. Found publicly lists Foundayo on its medication pages. Both Ro and Found can prescribe Foundayo. The practical difference is pricing transparency: Ro publishes cash-pay pricing directly on its site and matches LillyDirect rates; Found’s cash-pay pricing for branded medications is plan-dependent and less visible until you’ve selected a plan at checkout.
Is Ro or Found cheaper?
It depends on your scenario. Ro Body costs $39 the first month, then $149/month on a monthly plan or as low as $74/month on annual prepay. Medication is billed separately at matched LillyDirect and NovoCare cash-pay rates. Found’s CORE self-pay plan is $129/month. For members who want coaching-first at a lower membership fee, Found can be cheaper on membership alone. For members who want FDA-approved brand-name GLP-1s at transparent prices, Ro’s all-in monthly cost is easier to calculate.
Does Found charge a cancellation fee?
Found’s CORE Subscription Plans (Pay Monthly and Pay Quarterly) carry a $129 early termination fee if you cancel before day 151 of the commitment term, per Found’s published offer terms. Found Kickstart 3-, 6-, and 12-month plans also obligate you to pay all remaining fees through the final month. Some current plans include a 3-day full-refund window. Always read the specific plan terms before signing up.
Can I cancel Ro Body anytime?
Yes. Ro’s cancellation policy: cancel in your account or via email, at least 48 hours before your next renewal date. Paid membership fees are non-refundable. No early termination fee on the monthly plan. If you miss the 48-hour window, you’re charged for one more month.
Does Ro or Found accept insurance?
Both providers have insurance workflows. Ro’s insurance concierge fights for coverage and submits all prior authorization paperwork on your behalf; if coverage fails, your provider recommends a cash-pay alternative. Found runs a free GLP-1 coverage checker, contacts your insurer, returns a coverage report with PA requirements and estimated copays, and supports PA documentation. The key difference: at Ro, the concierge drives the PA through; at Found, more of that lift sits with you or your clinician.
Can either provider prescribe Ozempic or Mounjaro for weight loss?
Ro offers Ozempic. Found offers both Ozempic and Mounjaro. Both are FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss at provider discretion. Wegovy and Zepbound are the FDA-approved brand-name GLP-1s specifically approved for chronic weight management.
How fast do I get medication through each?
Ro: eligibility confirmed within 2 days; first dose typically under a week on cash-pay, or about 2 weeks on insurance (PA processing is typically the bottleneck at 2–3 weeks). Found: assessment plus provider review within 1–2 days; first-dose timelines vary by medication type and pharmacy routing. Both providers ship medication directly from network pharmacies for cash-pay options.
Can I use my HSA or FSA for either provider?
Prescription GLP-1 medications for qualifying medical conditions — obesity (BMI 30+) or overweight (BMI 27+) with a weight-related comorbidity — are generally HSA and FSA eligible at both Ro and Found. Membership fees themselves may or may not qualify depending on your plan administrator’s definition of qualified medical expenses. Confirm with your benefits administrator.
Should I switch from Found to Ro?
If your main reasons are transparent cash-pay pricing on oral GLP-1 pills (Foundayo and the Wegovy pill), an insurance concierge that submits your PA, or metabolic labs included at Quest — yes, Ro is the stronger fit. If Found’s coaching and community have been working and you don’t need those features, there’s no structural reason to switch. Before canceling Found, check your current plan’s specific cancellation terms — CORE commitment plans carry the $129 early termination fee before day 151.
Do I need either Ro or Found if I already have a prescription?
Not necessarily. If you already have an active prescription and a willing pharmacy, you can often fill it more cheaply through direct manufacturer programs — LillyDirect for Zepbound and Foundayo, NovoCare for Wegovy and Ozempic — or through an independent pharmacy. The telehealth membership makes sense when you need prescribing, ongoing clinical support, insurance help, or access to labs and titration guidance.
Are compounded GLP-1 medications at Ro or Found FDA-approved?
No. Compounded semaglutide and compounded tirzepatide are prepared by licensed compounding pharmacies and are not FDA-approved as finished drug products. The FDA has raised specific safety concerns about dosing errors and the use of salt forms in compounded injectable semaglutide. Both Ro and Found may offer compounded options where state law and current FDA guidance permit. If your preference is strictly FDA-approved medication, Ro has the deeper FDA-approved weight-loss-specific lineup.
How we verified this comparison
Every pricing figure and policy statement on this page was verified against each provider’s live website on April 22, 2026. We also cross-referenced FDA-approved drug labels, CMS Medicare GLP-1 Bridge documentation, and manufacturer cash-pay programs (LillyDirect, NovoCare, TrumpRx). Editorial judgments — like “Ro wins for most people” — are explicitly framed as editorial conclusions drawn from verified facts, not medical or clinical recommendations.
We have an affiliate relationship with Ro and no affiliate relationship with Found. That means we earn a referral commission when a reader starts with Ro through our link and don’t earn anything from a Found sign-up. We still recommend Found to the readers it fits because hiding Found’s strengths would wreck the trust we need to keep this page useful.
Primary sources verified April 22, 2026:
- ro.co/weight-loss/ and ro.co/weight-loss/pricing/
- ro.co/weight-loss/insurance/
- ro.co/weight-loss/foundayo/, ro.co/weight-loss/wegovy/, ro.co/weight-loss/zepbound/
- ro.co/terms-of-use/
- joinfound.com (program, pricing, medication, and terms pages)
- joinfound.com/medication/foundayo
- joinfound.com/terms/offer-terms and related versioned pages
- joinfound.com/terms/terms-and-conditions
- CMS Medicare GLP-1 Bridge documentation (last modified April 21, 2026)
- FDA press release on Foundayo/orforglipron approval (April 1, 2026)
- LillyDirect, NovoCare, TrumpRx manufacturer cash-pay programs
Re-verification cadence: monthly, and immediately on any FDA safety update, formulary change, or pricing announcement by either provider.
Related comparisons
Still not sure which GLP-1 program is right for you?
Tell us your insurance situation, your medication preference, your state, and a few other quick factors, and we’ll route you to the provider that actually fits — whether that’s Ro, Found, Eden, MEDVi, SHED, Enhance MD, or “none of the above, here’s what to do instead.”
Take the free 60-second GLP-1 matching quiz →Personalized recommendation. See your result instantly.
Written by: The RX Index Editorial Team · Published: April 22, 2026 · Last verified: April 22, 2026 · Review cadence: Monthly
Affiliate disclosure: This page contains affiliate links to Ro. If you sign up for Ro Body through one of our links, The RX Index earns a referral commission at no extra cost to you. We have no affiliate relationship with Found Health. The editorial ranking reflects our verified analysis of both providers, not the commercial relationship.
Not medical advice. GLP-1 medications carry serious risks including a boxed warning for thyroid C-cell tumors based on animal studies. Do not use GLP-1s if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Discuss any medication decision with a licensed healthcare provider.
